Mara Goldstein analyst MIZUHO

Currently out of the existing stock ratings of Mara Goldstein, 130 are a BUY (75.58%), 40 are a HOLD (23.26%), 2 are a SELL (1.16%).

Mara Goldstein

Work Performance Price Targets & Ratings Chart

Analyst Mara Goldstein, currently employed at MIZUHO, carries an average stock price target met ratio of 43.43% that have a potential upside of 37.13% achieved within 236 days.

Mara Goldstein’s has documented 320 price targets and ratings displayed on 33 stocks. The coverage is on Healthcare, Communication Services sectors.

Most recent stock forecast was given on RCUS, Arcus Biosciences at 30-Jan-2024.

Wall Street Analyst Mara Goldstein

Analyst best performing recommendations are on FTSV (FORTY SEVEN).
The best stock recommendation documented was for CRVS (CORVUS PHARMACEUTICALS) at 3/30/2023. The price target of $3.5 was fulfilled within 69 days with a profit of $2.71 (343.04%) receiving and performance score of 49.72.

Average potential price target upside

CELG Celgene CLDX Celldex Therapeutics CRVS Corvus Pharmaceuticals CTMX CytomX Therapeutics FATE Fate Therapeutics FTSV Forty Seven IMGN ImmunoGen INCY yte KDMN Kadmon Holdings MRK Merck mpany NLNK NewLink Genetics RDUS Schnitzer Steel Industries RLYP Relypsa TC TuanChe ADR AGTC Applied Genetic IOVA Iovance Biotherapeutics RCUS Arcus Biosciences SNSS Sunesis Pharmaceuticals EFTR Effector Therapeutics LUMO Lumos Pharma NKTR Nektar Therapeutics SGEN Seagen LPTX Leap Therapeutics ADAP Adaptimmune Therapeutics Plc NLTX Neoleukin Therapeutics ARDX Ardelyx AUTL Autolus Therapeutics Ltd ERAS Erasca IMRX Immuneering Corp TCRR Tcr2 Therapeutics VSTM Verastem XNCR Xencor INAB In8bio 

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$101

$-7.24 (-6.69%)

$101

4 years 11 months 11 days ago

2/8 (25%)

$-7.53 (-6.94%)

171

Hold

$115

$6.76 (6.25%)

$102

4 years 11 months 11 days ago

3/12 (25%)

$6.47 (5.96%)

382

Hold

$100

$-8.24 (-7.61%)

$128

5 years 1 months 23 days ago

3/6 (50%)

$4.78 (5.02%)

159

Buy

$102

$-6.24 (-5.76%)

$105

5 years 5 months 9 days ago

3/3 (100%)

$5.12 (5.28%)

270

Hold

$100

$-8.24 (-7.61%)

$100

5 years 6 months 7 days ago

2/7 (28.57%)

$5.2 (5.49%)

282

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Mara Goldstein?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?